Role of host factors in SARS-CoV-2 entry

por Evans, John P., Liu, Shan-Lu
Publicado 2021

SARS-CoV-2 and Emerging Foodborne Pathogens: Intriguing Commonalities and Obvious Differences

por Abdelhamid, Ahmed G., Faraone, Julia N., Evans, John P., Liu, Shan-Lu, Yousef, Ahmed E.
Publicado 2022

A kinetic intra-cellular assay (KICA) to measure quantitative compound binding kinetics within living cells

por Lay, Charles S., Thomas, Daniel A., Evans, John P., Jones, Emma J., Gatfield, Kelly M., Craggs, Peter D.
Publicado 2022

Defining Binding Efficiency and Specificity of Auxins for SCF(TIR1/AFB)-Aux/IAA Co-receptor Complex Formation

por Lee, Sarah, Sundaram, Shanthy, Armitage, Lynne, Evans, John P., Hawkes, Tim, Kepinski, Stefan, Ferro, Noel, Napier, Richard M.
Publicado 2013

Loss of Neutralizing Antibody Response to mRNA Vaccination against SARS-CoV-2 Variants: Differing Kinetics and Strong Boosting by Breakthrough Infection

por Evans, John P., Zeng, Cong, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Neutralizing antibody responses elicited by SARS-CoV-2 mRNA vaccination wane over time and are boosted by breakthrough infection

por Evans, John P., Zeng, Cong, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants

por Qu, Panke, Evans, John P., Kurhade, Chaitanya, Zeng, Cong, Zheng, Yi-Min, Xu, Kai, Shi, Pei-Yong, Xie, Xuping, Liu, Shan-Lu
Publicado 2022

Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants

por Qu, Panke, Evans, John P., Kurhade, Chaitanya, Zeng, Cong, Zheng, Yi-Min, Xu, Kai, Shi, Pei-Yong, Xie, Xuping, Liu, Shan-Lu
Publicado 2023

COVID-19 mRNA booster vaccines elicit strong protection against SARS-CoV-2 Omicron variant in patients with cancer

por Zeng, Cong, Evans, John P., Chakravarthy, Karthik, Qu, Panke, Reisinger, Sarah, Song, No-Joon, Rubinstein, Mark P., Shields, Peter G., Li, Zihai, Liu, Shan-Lu
Publicado 2022

Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant

por Qu, Panke, Evans, John P., Zheng, Yi-Min, Carlin, Claire, Saif, Linda J., Oltz, Eugene M., Xu, Kai, Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

SARS-CoV-2 Spreads through Cell-to-Cell Transmission

por Zeng, Cong, Evans, John P., King, Tiffany, Zheng, Yi-Min, Oltz, Eugene M., Whelan, Sean P. J., Saif, Linda, Peeples, Mark E., Liu, Shan-Lu
Publicado 2021

Neutralizing antibody responses against SARS-CoV-2 in vaccinated people with multiple sclerosis

por Gyang, Tirisham V., Evans, John P., Miller, Joseph S., Alcorn, Kariss, Peng, Juan, Bell, Erica H., Zeng, Cong, Gumina, Richard, Liu, Shan-Lu, Segal, Benjamin M.
Publicado 2022

Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

Erratum for Zeng et al., “Neutralization of SARS-CoV-2 Variants of Concern Harboring Q677H”

por Zeng, Cong, Evans, John P., Faraone, Julia N., Qu, Panke, Zheng, Yi-Min, Saif, Linda, Oltz, Eugene M., Lozanski, Gerard, Gumina, Richard J., Liu, Shan-Lu
Publicado 2021

SARS-CoV-2 spreads through cell-to-cell transmission

por Zeng, Cong, Evans, John P., King, Tiffany, Zheng, Yi-Min, Oltz, Eugene M., Whelan, Sean P. J., Saif, Linda J., Peeples, Mark E., Liu, Shan-Lu
Publicado 2021

Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants

por Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Yu, Lianbo, Ma, Qin, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022

Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors

por Zeng, Cong, Evans, John P., Pearson, Rebecca, Qu, Panke, Zheng, Yi-Min, Robinson, Richard T., Hall-Stoodley, Luanne, Yount, Jacob, Pannu, Sonal, Mallampalli, Rama K., Saif, Linda, Oltz, Eugene, Lozanski, Gerard, Liu, Shan-Lu
Publicado 2020

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants

por Evans, John P., Qu, Panke, Zeng, Cong, Zheng, Yi-Min, Carlin, Claire, Bednash, Joseph S., Lozanski, Gerard, Mallampalli, Rama K., Saif, Linda J., Oltz, Eugene M., Mohler, Peter J., Gumina, Richard J., Liu, Shan-Lu
Publicado 2022